Guizhou Bai Ling Pharmaceutical Group Co., Ltd. 2025 Annual Board of Directors Work Report
In 2025, the Company's Board of Directors strictly abided by laws and regulations such as the "Company Law" and "Securities Law," and the "Articles of Association," diligently performed its duties as entrusted by the Shareholders' Meeting, strictly implemented the resolutions of the Board of Directors, conscientiously carried out various tasks, and actively promoted the development of the Company's various businesses. The Board of Directors has always been based on the Company's long-term development and the interests of all shareholders, focusing on the Company's development strategy and work policy, and actively promoting the development of the Company's various businesses. In accordance with the development strategy set at the beginning of the year, various tasks have been diligently promoted, and the Company's various businesses have maintained a good development momentum. The work report for the Company's 2025 Board of Directors is as follows:
I. Board of Directors' Daily Work
(I) Board Meetings and Decision-Making
In 2025, the Company's Board of Directors held 9 meetings. The procedures for convening and holding the meetings, the qualifications of attendees, the voting procedures, the voting results, and the content of the resolutions all complied with the provisions of laws and regulations and the "Articles of Association." The Board deliberated on important matters such as the Company's external guarantees, profit distribution, periodic reports, and bank loans.